Anti-Malarial Drugs Demonstrate Potential in Covid-19 Treatment
Anti-Malarial Drugs Anti-malarial drugs are used in the treatment of malaria. Most antimalarial drugs target the erythrocytic stage of infection that causes symptomatic illness. These include, Atovaquone/Proguanil (Malarone), Chloroquine, Doxycycline, Mefloquine, Primaquine, and Tafenoquine (Arakoda). Chloroquine is the preferred treatment for any parasite. Tropomyosin or thyroxine are used to prepare these drugs. The drugs contain both antimalarials and topical agents for the purpose of alleviating the pain caused by malaria. High prevalence of malaria around the world is primarily boosting demand for Anti-Malarial Drugs . In 2020 an estimated 241 million cases of malaria occurred worldwide and 627,000 people died, mostly children in sub-Saharan Africa. About 2,000 cases of malaria are diagnosed in the U.S annually. Several companies are focused on approval and launch of new drugs for the treatment of malaria. In May 2020, The U.S. Food and Drug Administration approved artes...